Loading clinical trials...
Loading clinical trials...
CLP-0019- FebriDx® Method Comparison Study Protocol
The goal of this observational study is to learn about the performance and ease of use of FebriDx when operated by persons without laboratory experience or training in patients with acute respiratory symptoms. The main question it aims to answer is: • Is FebriDx accurate at differentiating bacterial from non-bacterial respiratory infections when used by untrained operators? Trained and untrained participants will run the FebriDx test on patients with respiratory symptoms to evaluate comparability.
A prospective, multi-center, blinded observational study to demonstrate that the FebriDx test meets the CLIA statutory criteria for waiver by providing sufficient assurance that the addition of a new operator population (untrained) and environment of use (waived) will not adversely impact the performance or safety of the test. The study aims to: * Demonstrate that FebriDx® Test is accurate and the operator can perform the test with a negligible risk of erroneous result. * As a secondary objective, ease-of-use objective data and subjective feedback relating to the device and its operator interface will be collected at the end of the study and assessed for comparability.
Age
12 - 64 years
Sex
ALL
Healthy Volunteers
No
Ascada Health
Fullerton, California, United States
Exer Urgent Care
Pasadena, California, United States
L&C
Miami, Florida, United States
Trujillo Medical Center
Miramar, Florida, United States
Hillcrest Medical Research, LLC
Orange City, Florida, United States
Hometown Urgent Care and Research
Beavercreek, Ohio, United States
HMG Clinical Research/Herrera Medical Group
Bedford, Texas, United States
Ascada Health
Katy, Texas, United States
Start Date
December 20, 2024
Primary Completion Date
August 15, 2025
Completion Date
August 31, 2025
Last Updated
September 9, 2025
800
ACTUAL participants
Rapid point of care test to detect host immune response in ARI
DIAGNOSTIC_TEST
Lead Sponsor
Lumos Diagnostics
Collaborators
NCT07211997
NCT07075029
NCT01767064
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions